Journal
BMC MICROBIOLOGY
Volume 8, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1471-2180-8-132
Keywords
-
Categories
Funding
- Estonian Science Foundation [0182555]
- GARMB [5042, 6782]
- TARMB [0418]
- TARBK [0411]
- Estonian Technology Agency [01103]
- Centre of Excellence of Molecular and Clinical Medicine, University of Tartu
Ask authors/readers for more resources
Background: The aim of the study was to detect whether in experimental Salmonella enterica Typhimurium infection the probiotic Lactobacillus fermentum ME-3 in combination with fluoroquinolone therapy would eradicate S. Typhimurium, prevent the development of liver and spleen granulomas and improve the indices of oxidative stress in the ileum mucosa. The selected bacteriological, histological and biochemical methods were applied. Results: Combined treatment with L. fermentum ME-3 and ofloxacin eradicated Salmonella Typhimurium from blood, ileum and liver, decreased the number of animals with liver and spleen granulomas and reduced the value of lipid peroxides in the ileum mucosa. Higher total counts of intestinal lactobacilli in all experimental groups were associated with the absence of liver granulomas. Conclusion: The antimicrobial and antioxidative probiotic L. fermentum ME-3 combined with ofloxacin enhances the eradication of experimental S. Typhimurium infection. These observations on probiotic and antimicrobial co-action may serve as basis to develop new strategies for treatment of invasive bacterial infections of the gut.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available